Afrooz Rashnonejad

3PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapyMolecular targetsMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 20, 2025
Sustained efficacy of CRISPR-Cas13b gene therapy for FSHD is challenged by immune response to Cas13b.

Afrooz Rashnonejad, Manal Farea, Gholamhossein Amini-Chermahini

|May 15, 2023
Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models.

Renatta N Knox, Jocelyn O Eidahl, Lindsay M Wallace

Pageof 1